Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6317-6324
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 346
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 112
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Sangwook Oh, Xuming Mao, Sílvio M. Vieira, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 9, pp. 1229-1238
Open Access | Times Cited: 89
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
Chuan Qin, Dai‐Shi Tian, Luo‐Qi Zhou, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 80
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
S. Momsen Reincke, Niels von Wardenburg, Marie A. Homeyer, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5084-5097.e18
Open Access | Times Cited: 66
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 58
Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases
Alexander Schäbitz, Christina Hillig, Mohammad S. Mubarak, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Opportunities and limitations of B cell depletion approaches in SLE
Marit Stockfelt, Y.K. Onno Teng, Edward M Vital
Nature Reviews Rheumatology (2025)
Closed Access | Times Cited: 1
Applications of Cell-Based Protein Array Technology to Preclinical Safety Assessment of Biological Products
Axel Vicart, Cam Holland, Kathryn Fraser, et al.
Toxicologic Pathology (2025)
Closed Access | Times Cited: 1
Is There a Place for Chimeric Antigen Receptor–T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Cindy Orvain, Morgane Boulch, Philippe Bousso, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 11, pp. 1954-1965
Open Access | Times Cited: 48
B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
Carlo G. Bonasia, Wayel H. Abdulahad, Abraham Rutgers, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1190-1190
Open Access | Times Cited: 42
Immunopathology and Immunotherapy of Inflammatory Skin Diseases
Ahreum Song, Sang Eun Lee, Jong Hoon Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Emerging strategies for treating autoimmune disorders with genetically modified Treg cells
Dominic A. Boardman, Megan K. Levings
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 1, pp. 1-11
Closed Access | Times Cited: 29
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Closed Access | Times Cited: 19
Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
Kavina Shah, Maria Leandro, Mark S. Cragg, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 1, pp. 15-30
Open Access | Times Cited: 6
Application of novel CAR technologies to improve treatment of autoimmune disease
Abigail Cheever, Chloe C. Kang, Kim L. O’Neill, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders
Chrysoula Zografou, Aigli G. Vakrakou, Panos Stathopoulos
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways
Christoph T. Ellebrecht, Damián Maseda, Aimee Payne
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 3, pp. 907-914
Open Access | Times Cited: 33
Autoimmune Pemphigus: Latest Advances and Emerging Therapies
Yen Loo Lim, G. Bohelay, Sho Hanakawa, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 26
Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
Carlos M. Moreno, Christopher Haynie, Abigail Cheever, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 25
Meeting report – Desmosome dysfunction and disease: Alpine desmosome disease meeting
Volker Spindler, Brenda Gerull, Kathleen J. Green, et al.
Journal of Cell Science (2023) Vol. 136, Iss. 1
Open Access | Times Cited: 15
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
Luca Perico, Federica Casiraghi, Fabiane Sônego, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Immunobullous Diseases
Enno Schmidt, Richard Groves
(2024), pp. 1-83
Closed Access | Times Cited: 5
Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations
Beatriz Martín-Antonio, Belén Blanco, África González‐Murillo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Depletion of alloreactive B cells by drug- resistant chimeric alloantigen receptor T cells to prevent transplant rejection
Anna Christina Dragon, Agnes Bonifacius, Stefan Lienenklaus, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1031-1047
Open Access
Page 1 - Next Page

Scroll to top